Enterprise Pharmacy Recalls Nifedipine Bags Due to Sterility Concerns
CMC Enterprise Pharmacy is recalling 1,783 bags of Nifedipine 25 mg in NS 250 mL due to a lack of sterility assurance. The affected products were distributed in North Carolina.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II and involves a lack of sterility assurance in an injectable medication, which poses a risk of serious infection or adverse health consequences.
Plain-English summary
CMC Enterprise Pharmacy is recalling 1,783 bags of NICARdipine 25 mg in NS 250 mL EXCEL bag. The recall was initiated because of a lack of sterility assurance in the manufacturing process. The affected products were distributed in North Carolina.
The recall includes specific lots with expiration dates ranging from April 16, 2019, to June 25, 2019. The lot numbers are EA161909, EA211907, EB041906, EB111908, EB181907, EB251910, EC111908, EC201909, EC261909, and EC271919. The FDA has classified this recall as Class II, indicating that use of, or exposure to, the violative product may cause temporary or medically reversible adverse health consequences.
Healthcare providers and patients should stop using the affected products and contact CMC Enterprise Pharmacy for further instructions or a replacement. Consumers should not use the recalled bags and should return them to the pharmacy where they were obtained.
The recalled product
- Product
- NICARdipine 25 mg in NS 250 mL EXCEL bag, Made by: Enterprise Pharmacy, 4400 Golf Acres Drive, Bldg. J Suite E, Charlotte, NC, 28208.
- Manufacturer
- CMC Enterprise Pharmacy
- Category
- Drug — Injectable
- Affected units
- 1,783
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (10)
- Lots: EA161909 Exp. 4/16/2019
- EA211907 Exp. 4/21/2019
- EB041906 Exp. 5/5/2019
- EB111908 Exp. 5/12/2019
- EB181907 Exp. 5/19/2019
- EB251910 Exp. 5/26/2019
- EC111908 Exp. 6/9/2019
- EC201909 Exp. 6/18/2019
- EC261909 Exp. 6/24/2019
- EC271919 Exp. 6/25/2019
Distribution
Distributed in 1 state:
Part of a larger recall action
This product is one of 32 recalled by CMC Enterprise Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 32 products in this recall →Related recalls
Same manufacturer · CMC Enterprise Pharmacy
See all →- SevereCMC Enterprise Pharmacy Recalls CeFAZolin Due to Lack of Sterility Assurance
FDA (Drugs) · 2019-05-01
- SevereCMC Enterprise Pharmacy Recalls Oxytocin Bags Due to Sterility Concerns
FDA (Drugs) · 2019-05-01
- SevereCMC Enterprise Pharmacy Recalls Vancomycin Bags Due to Sterility Concerns
FDA (Drugs) · 2019-05-01
- SevereDiltiazem 250 mg IV Bags Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2019-05-01
- SevereCMC Enterprise Pharmacy Recalls Magnesium Sulfate Bags Due to Sterility Concerns
FDA (Drugs) · 2019-05-01
Same hazard · sterility
See all →- HighFDA recalls injectable compounded mixture in single-use syringes
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Semaglutide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Leader Advanced Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
Similar recalls
- SeverePharMEDium Recalls nICARdipine HCl Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2020-04-15
- HighNORepinephrine Injectable Recalled Nationwide for Sterility Assurance Failure
FDA (Drugs) · 2023-05-31
- HighHealth Innovations Pharmacy Recalls Naltrexone Capsules Due to Sterility Concerns
FDA (Drugs) · 2015-05-20
- SevereSentara Recalls Nafcillin Bags Due to Sterility Assurance Concerns
FDA (Drugs) · 2016-02-03
- HighNORepinephrine IV Bags Recalled for Sterility Assurance Failure
FDA (Drugs) · 2023-08-09
- SevereSentara Recalls Ampicillin/Sulbactam Bags Due to Sterility Concerns
FDA (Drugs) · 2016-02-03